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Several aspects of the specific modification of cellobiohydrolase I (CBH I) from Trichoderma reesei with Woodward's 
reagent K (N-ethyl-5-phenylisoxazolium-Y-sulfonate) are presented. The pH dependence of the resulting inactivation 
points to the implication of an ionising roup with a pKa of approx. 5.5. The rapid inactivation kinetics, the specific 
protection and the stoichiometry of modification (3 versus 2 residues), together with the isolation and amino acid se- 
quencing of the putative active site peptide, provide a large body of evidence for the presence of a catalytically important 
carboxyl residue in the 125-135 region of the CBH I amino acid sequence. From the striking homology between this 
peptide sequence and those of the active site regions of different lysozymes, glutamic acid 126 is retained as the most 
plausible catalytic residue (proton donor) in CBH I, equivalent toglutamic acid 35 in hen egg white lysozyme. Glutamic 
acid 127 is proposed as a potential active site residue to the homologous endoglucanase I (EG I) isolated from the same 
Trichoderma species. 
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1. INTRODUCTION 
The fungus Trichoderma reesei, one of the most 
efficient cellulolytic organisms, ecretes an enzyme 
system composed of two cellobiohydrolases, 
CBH I and CBH II (EC 3.2.1.91), at least three 
endoglucanases, EG I, II and III (EC 3.2.1.4) and 
several ff-glucosidase (EC 3.2.1.21). 
Correspondence address: M. Claeyssens, Laboratorium voor 
Biochemie, Rijksuniversiteit Gent, K.L. Ledeganckstraat 35, 
9000 Gent, Belgium 
Abbreviations: CBH I, cellobiohydrolase (EC 3.2.1.91); core I, 
core-protein ofCBH I; EG, endogiucanase (EC 3.2.1.4); WRK, 
N-ethyl-5-phenylisoxazolium-3'-sulfonate; DEP, diethylpyro- 
carbonate; NBS, N-bromosuccinimide; TNM, tetranitro- 
methane; Mes, N-morpholinomethane-sulfonic acid; Tris, tris- 
(hydroxymethyl)aminomethane; CNPL, 2'-chloro-4'-nitro- 
phenyl B-lactoside; TFA, trifluoroacetic acid; RP-HPLC, 
eeversed-phase high pressure liquid chromatography; DTT, 
dithiothreitol; Gu.HC1, guanidine hydrochloride 
The cloning and/or sequencing of some of these 
enzymes and their genes have led to detailed struc- 
tural information [1-7]. Thus EG I and CBH I 
share about 45% sequence homology [6]. Partial 
proteolysis tudies of CBH I [8] and. CBH II [9] 
have further evealed the existence of two distinct 
functional domains: a binding region for insoluble 
cellulose and a core protein containing the active 
(hydrolytic) site. The binding domains have been 
identified with terminal, glycosylated amino acid 
sequences (block AB (B')) conserved in both en- 
zymes [3,7]. From physical measurements on the 
intact enzymes and their core proteins, it was 
shown that these binding domains protrude from 
the ellipsoidal cores as flexible tails [10]. 
Although a 'lysozyme-like' mechanism was 
postulated for these glycosylases a  early as 1963 
[11], only sparse vidence has been obtained so far 
to support his hypothesis [12-14]. 
Modification studies of carboxyl group(s) in 
CBH I and its core protein are reported here. The 
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isolation of an active site peptide containing a
putatively essential glutamate group is described. 
2. MATERIALS AND METHODS 
2.1. Materials 
N-Ethyl-5-phenylisoxazolium-3 '-sulfonate (Woodward's re- 
agent K, WRK) was purchased from Sigma (USA); 
diethylpyrocarbonate (DEP), N-bromosuccinimide (NBS) and 
tetranitromethane (TNM) were from Aldrich (Belgium). Biogel 
P-6 and P-100 were obtained from Bio-Rad (USA). 
Microcrystalline cellulose (Avicel pH 101) was from FMC 
Corp. (USA). 2'-Chloro-4-nitrophenyl ~'-lactoside was 
prepared conventionally [15]. Rhodymenia p lmate xylan was a 
gift from Dr R. Sturgeon (Edinburgh). The molecular mass was 
estimated to be approx. 3000 Da (d.p. 25-30) (Dr Abuja, per- 
sonal communication). All other substrates, ligands and 
chemicals were either prepared in our laboratory or obtained 
commercially. 
2.2. Enzymes and enzymic assays 
CBH I was purified from the culture filtrate of the fungus 
Trichoderma reesei QM 9414 (kindly donated by Dr J. 
Knowles, VTT, Espoo, Finland) by affinity chromatography 
[16]. Core I protein was obtained by papaln digestion and 
purified as previously described [8]. The molar absorption coef- 
ficients (280 nm) of intact CBH I and its core are identical ~m 
= 73000 M- l -cm -1 [8]. 
CNPL (1 raM) was used as a routine substrate to determine 
CBH I activities at pH 5.7 and 37°C. Interaction (inhibition) 
constants of ligands were determined conventionally (1/v vs [I] 
plots) or by active site titrations as described in [17], using the 
same lactoside as indicator substrate. Avicel suspensions 
(30 mg" m1-1 in 50 mM sodium acetate/acetic a id, pH 5.0) 
were used to study the activity (50°C) and adsorption (20°C) of 
CBH I against and onto this substrate as described [9]. 
2.3. Enzyme modifications 
An aliquot of a fresh stock solution of WRK reagent [18] 
(250 mM in 1 mM HCI) was diluted 1 : 2 in 50 mM Mes/NaOH 
buffer, PH 5.5, and added (20°C) to CBH I or core I 
(15-20/~M) (final WRK concentrations 10-70 mM). The pH of 
the stirred reaction mixture was kept constant by manual titra- 
tion (0.1 N NaOH), at indicated times, 30/~1 aliquots were 
diluted in 400/~1 50 mM sodium acetate, pH 5.7, to quench the 
inactivation reaction, and the residual activity measured using 
CNPL. Inactivations in the presence of protecting ligands were 
performed similarly, and the pH dependence was investigated 
by incubating 17.5/~M enzyme with 50 mM WRK in 50 mM 
Mes/NaOH buffers of pH range 4.6-6.5. Modifications with 
other reagents were according to published procedures: histidyl 
residues with diethylpyrocarbonate (DEP) [19]; tryptophanyl 
residues with N-bromosuccinimide (NBS) [20]; tyrosyl residues 
with tetranitromethane (TNM) [21]. 
2.4. Isolation of WRK-modified enzyme and peptide analysis 
Core I solution (2 ml 15-20/~M) was treated with WRK 
(50-150 mM) in 50 mM Mes/NaOH buffer, pH 5.5 (20°C) in 
the absence or presence of ligands (cone. given). After adding 
sodium acetate (250 mM final concentration) the mixture was 
applied immediately onto a Biogel P-6 column (20 x 1 cm) 
equilibrated with 50 mM sodium acetate, pH 5.0, or 10 mM 
Tris-HCl buffer, pH 8.0 (1 ml. min-l). UV-difference spectra 
of the protein fractions were recorded (Uvicon 810, Kontron, 
Switzerland), and the degree of modification was determined 
from the 340/280 nm ratio using ~M = 7000 M - I. cm- ~, pH 8.0, 
at 340 nm [22]. The modified enzyme (700/~!, 30-50/~M in pH 
8.0 buffer) was treated subsequently with 0.7 g Gu.HC1 and 
2.8 mg DTT under N2 and left at 25°C for 4 h [23]. The re- 
duced sample, diluted with 1.5 ml 100 mM Tris-HCl buffer, pH 
8.0 ,  and concentrated to -0.5 ml, was treated with subtilisin 
(Boehringer, FRG) (1/100, w/w; 10 rain; 37°C). A sample 
(150 pg) was injected on a C4-Vydac 214 TP-54 column (0.46 x 
25 cm) and eluted with a linear gradient of 0.05°7o TFA (solvent 
A) and 70o70 CH3CN/0.05% TFA (solvent B). Fractions ab- 
sorbing at 340 nm were collected and used for amino acid and 
N-terminal sequencing analysis according to published pro- 
cedures [24] (gas-liquid-phase quencer, Applied Biosystems 
Inc., USA). 
3. RESULTS AND DISCUSSION 
3.1. Inactivation reaction kinetics 
After 9 min incubation of 17.5/~M CBH I with 
s[  _ .  
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Fig.l. (A) Inactivation of 17.5/~M CBH I with various concentrations of WRK: (1) 0, (2) 5, (3) 10, (4) 20, (5) 30 and (6) 50 mM in 
50 mM Mes/NaOH buffer, pH 5.5 (20°C). Residual activities were determined as described in section 2. (B) Plot of the kapp values, 
derived from the slopes of the lines in A, versus WRK concentration. (C) Effect of pH on kapp (see section 2). 
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50 mM WRK (pH 5.5, 20°C) residual activity 
against he lactoside is only 1007o. The time-course 
of inactivation (fig. 1A) is linear, and a plot of the 
pseudo-first-order constants against he modifier 
concentration is hyperbolic (fig. 1B). The reaction 
probably proceeds with formation of an in- 
termediary, reversible enzyme-modifier complex 
(saturation with respect to WRK) and the 
modification thus seems active site directed. From 
the linearised [WRK]/kapv ersus [WRK] plot (not 
shown), the composite association (K¢ = 
44.5 M-l), the maximal inactivation (kmax = 
6.3 min -1) and the second-order rate constants (k' 
= 13 min -l .M -1) can be derived. Analysis [25] of 
a log (kapv) versus log [WRK] plot (not shown) 
yields a reaction order with respect to WRK of 1.1 
( +_ 0.2) and thus indicates that at least one essential 
group is present in CBH I. The modification pro- 
ceeds most rapidly at pH 5.5 and the bell-shaped 
pH inactivation curve indicates that two groups 
with apparent pKa values of 5.4 and 5.8 are im- 
plicated (fig.lC). This could either be (i) histidyl 
group(s) with an abnormally low pKa or (ii) car- 
boxyl group(s) with a high pKa value. As the pH- 
activity curves for CBH I are similarly shaped and 
two catalytic important groups with pKa values of 
3.7 and 5.0 can be deduced (Van Tilbeurgh et al., 
unpublished), modification with WRK could be 
directed towards the latter group. Proofs regarding 
the nature of the modified residue and the 
homogeneity of the partially and fully modified 
enzymes are given below (3.2 and 3.3). 
Cellobiose (40/~M, Ki = 16/JM), lactose 
(400/zM, Ki = 312/zM), as competitive inhibitors, 
as well as substrates (e.g. cellotriose 140/aM, 
Kmi -- 12/¢M) protect effectively against inactiva- 
tion (66, 65 and 77070, respectively). 
Due to the high interaction constant of xylan 
(Rhodymenia p lmata) (Ki = 0.4/zM) and the dif- 
ficulty in removing (dialysis) this high molecular 
mass inhibitor, protective ffects cannot unam- 
biguously be evaluated. A correlation between 
modification and protection by this ligand can, 
however, clearly be established (see below). 
3.2. Stoichiometry and specificity of the 
modification reaction 
A characteristic maximum at 340 nm in UV 
spectra of CBH I, indicative of a chromophore 
formed by reaction between the enol-ester of WRK 
and carboxyl groups of the enzyme [18,26], can be 
demonstrated. The number of modified carboxyl 
groups estimated from the 340/280 nm ratio 
amounts to three under the conditions given 
(17.5/zM CBH I, 50 mM WRK, pH 5.5). In the 
presence of 20-100/zM xylan, one group can ob- 
viously be protected. With smaller or less tightly 
binding inhibitors or substrates (e.g. cellobiose or 
cellotriose) the effect is only partial (2.5-3.0 
groups modified). This can, however, be artefac- 
tual, since after gel filtration modified enzyme 
preparations are obtained with lower specific ac- 
tivities, indicating incomplete protection and fur- 
ther inactivation during this purification step. 
WRK can modify amino acid residues other than 
carboxyl groups (e.g. Trp, Tyr, His and Cys). All 
cysteinyl residues in CBH I are present in disulfide 
bridges [27] and reaction of these residues with 
WRK can thus be excluded. N-Ethoxy- 
carboxylation f three histidyl groups with DEP in 
CBH I does not lead to loss of activity, proving the 
nonessentiality of these residues (not shown). 
Reaction with NBS or with TNM results in com- 
plete inactivation (modification of Trp) or three- 
fold activation (nitration of Tyr), respectively. The 
former inactivation reaction, however, cannot be 
prevented by the use of specific inhibitors uch as 
cellobiose or cellotriose (unpublished results). 
Specific modification of carboxyl groups in CBH I 
by WRK can thus be assumed. 
3.3. Properties of the modified enzyme 
After partial modification (quenching of inac- 
tivation reaction with acetate, 24°7o residual activi- 
ty) the kinetic parameters (pH 5.7, 37°C) of CBH I 
for CNPL show a small decrease in Km (504/zM vs 
427/~M) but a large decrease in keat (10.9 min -1 vs 
2.7 min-1). Activity against Avicel is similarly af- 
fected (8007o decrease) but the adsorption on the 
same substrate is only slightly decreased (1207o). 
From our previous work on the bifunctional 
organisation of CBH I [8], it becomes clear that 
the modification with WRK is directed against the 
catalytic domain present in the core fragment and 
not against the cellulose-binding region (BA 
glycopeptide domain) which is seemingly left in- 
tact. An enzyme sample with 40070 residual activity 
is bound in approximately the same amount onto 
an affinity column carrying p-aminobenzyl 1-thio 
cellobioside as ligand and the retained fraction is 
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completely desorbed by lactose [16]. This proves 
the homogeneity of the modified enzyme prepara- 
tions and again the active site-directed character of 
the modification. 
Also the mobility of the enzyme on SDS-PAGE 
is unaffected by partial or complete WRK inactiva- 
tion, proving that no intermolecular c oss-linking 
occurred. 
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Fig.2. RP-HPLC elution profiles of a subtilisin digest of 
reduced CBH I after modification in tlie absence (A) or 
presence (B) of 100/~M xylan; 214 (lower) and 340 nm (upper) 
tracings. Peptides I and I '  were collected and sequenced. 
3.4. Isolation of an active-site peptide 
Peptide mapping (subtilisin) with specific detec- 
tion at 340 nm [28] was tried to isolate modified 
residues (fig.2). Chromatograms of modified and 
protected (xylan) enzyme samples coincide (214 
tracings). The absence of one peak (340 nm trac- 
ings) in the latter case provides proof for the 
presence of one or more active-site residues in 
these peptides (I' versus I, fig.2). The results of the 
N-terminal sequencing analysis (10-15 steps) were 
identical for both (fig.3) and amino acid analysis 
reveals that their actual length is approximately 
13-17 residues (results not given). The corre- 
sponding region in the CBH I sequence [1,2] is 
found between residues 125-135 as shown in the 
alignment (fig.3). Three carboxyl groups are pre- 
sent and it cannot be unambiguously determined 
which were modified. 
A homology search with known active-site 
regions of several lysozymes [29] is, however, 
revealing (fig.3). Taking into account possible 
deletions and inversions these sequences eem 
highly conserved and the choice of Glu-126 as a 
putative active site residue in CBH I becomes 
plausible. EG I, with an equally conserved amino 
acid sequence [6], is inactivated by WRK very 
similarly to CBH I (Tomme, unpublished), and 
Glu-127 is consequently proposed as an active site 
residue (fig.3). The location of these residues, both 
in CBH I and EG I,  between two large protein do- 
mains, as deduced from a disulfide bridge reparti- 
tion study [27], is diagnostic for an active site 
(cleft). Although ydrophobicity is high in all these 
peptide sequences, two Asp residues (130, 132) 
seem to confer some polarity to the presumed ac- 
tive site of CBH I. This is probably reflected in the 
somewhat lower pKa value of the modifiable car- 
BClbOO~ milk L. R 
Duck egg L. N - 
HEW L. K 
CBH I G N F 
EGI  G Q L 
ovsa  
D L S A  
Fig.3. Alignment of the sequence of the isolated peptides (I, 1 ' ) 
(determined sequence in bold face) with the corresponding 
region in the CBH I sequence [1,2], the homologous region in 
EG I [6] and known active site regions of several ysozymes 
[29]. Conserved (boxed), chemically exchangeable (underlined) 
and putatively deleted ( - )  amino acids are indicated. 
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boxyl groups (5.4-5.8) in the latter as compared to 
that of Glu-35 in hen egg-white lysozyme (pKa 6.3). 
The glutamic acids found in this study (Glu-126 in 
CBH I and Glu-127 in EG I) are obvious targets 
for site-directed mutagenesis, especially since 
several successful cloning experiments of these en- 
zymes have been described [30]. 
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